PROCEPT BioRobotics Corporation (BMV:PRCT)
543.54
+7.54 (1.41%)
At close: Jan 22, 2026
PROCEPT BioRobotics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 286.5 | 333.73 | 257.22 | 221.86 | 304.32 |
Cash & Short-Term Investments | 286.5 | 333.73 | 257.22 | 221.86 | 304.32 |
Cash Growth | -14.15% | 29.74% | 15.94% | -27.10% | 203.93% |
Receivables | 83.53 | 83.5 | 48.38 | 15.27 | 4.46 |
Inventory | 70.69 | 56.17 | 39.76 | 28.54 | 13.15 |
Prepaid Expenses | 9.21 | 8.1 | 5.15 | 6.18 | 4.24 |
Restricted Cash | - | - | - | 0.78 | - |
Other Current Assets | 0.44 | 0.36 | 0.06 | - | - |
Total Current Assets | 450.38 | 481.84 | 350.57 | 272.63 | 326.17 |
Property, Plant & Equipment | 47.94 | 45.65 | 48.99 | 32.14 | 8.32 |
Other Intangible Assets | 0.71 | 0.93 | 1.2 | 1.48 | 1.75 |
Long-Term Deferred Charges | 1.27 | 0.84 | 0.49 | - | - |
Other Long-Term Assets | 7.78 | 4.75 | 3.47 | 3.09 | 0.78 |
Total Assets | 508.08 | 534.02 | 404.72 | 309.33 | 337.02 |
Accounts Payable | 17.29 | 10.03 | 13.5 | 9.39 | 2.03 |
Accrued Expenses | 32.4 | 28.59 | 21.52 | 19.16 | 9.56 |
Current Portion of Long-Term Debt | - | 2 | 1.89 | - | - |
Current Portion of Leases | 2.21 | 1.91 | 1.68 | 2.13 | 2.11 |
Current Unearned Revenue | 13.05 | 9.57 | 5.66 | 2.86 | 1.03 |
Other Current Liabilities | 0.85 | 1.03 | 1.69 | 1.76 | 1.52 |
Total Current Liabilities | 65.8 | 53.13 | 45.93 | 35.29 | 16.24 |
Long-Term Debt | 51.62 | 51.47 | 51.34 | 52.99 | 51.5 |
Long-Term Leases | 24.65 | 26.87 | 26.18 | 23.98 | 1.99 |
Other Long-Term Liabilities | 0.15 | 0.32 | 0.52 | - | 0.2 |
Total Liabilities | 142.21 | 131.8 | 123.97 | 112.26 | 69.93 |
Additional Paid-In Capital | 1,007 | 948.09 | 735.24 | 545.75 | 528.67 |
Retained Earnings | -641.56 | -545.99 | -454.57 | -348.68 | -261.52 |
Comprehensive Income & Other | 0.04 | 0.11 | 0.08 | -0.01 | -0.05 |
Total Common Equity | 365.87 | 402.22 | 280.75 | 197.07 | 267.09 |
Shareholders' Equity | 365.87 | 402.22 | 280.75 | 197.07 | 267.09 |
Total Liabilities & Equity | 508.08 | 534.02 | 404.72 | 309.33 | 337.02 |
Total Debt | 78.48 | 82.25 | 81.09 | 79.1 | 55.6 |
Net Cash (Debt) | 208.02 | 251.48 | 176.13 | 142.76 | 248.72 |
Net Cash Growth | -17.28% | 42.78% | 23.37% | -42.60% | 470.65% |
Net Cash Per Share | 3.75 | 4.82 | 3.73 | 3.22 | 15.09 |
Filing Date Shares Outstanding | 56.39 | 54.82 | 50.96 | 44.87 | 43.99 |
Total Common Shares Outstanding | 56.32 | 54.72 | 50.77 | 44.83 | 43.68 |
Working Capital | 384.58 | 428.71 | 304.64 | 237.34 | 309.93 |
Book Value Per Share | 6.50 | 7.35 | 5.53 | 4.40 | 6.12 |
Tangible Book Value | 365.16 | 401.29 | 279.55 | 195.6 | 265.34 |
Tangible Book Value Per Share | 6.48 | 7.33 | 5.51 | 4.36 | 6.08 |
Machinery | 25.82 | 21.79 | 16.51 | 4.57 | 3.96 |
Construction In Progress | 4.11 | 0.26 | 3.55 | 5.67 | - |
Leasehold Improvements | 13.23 | 12.49 | 12.36 | 4.94 | 4.94 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.